Description
DEOBLIGATE EXCESS FUNDS FROM ORDER BLOOD AND BLOOD PRODUCTS BHVAHCS
Base award description: BLOOD AND BLOOD PRODUCTS BHVAMC, OP4 TO
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-10-01+$96,077= $96,077
- Mod P000012024-10-10+$0= $96,077
- Mod P000022026-06-02-$54,225= $41,852
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-10-01 | +$96,077 | $96,077 | BLOOD AND BLOOD PRODUCTS BHVAMC, OP4 TO |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2024-10-10 | +$0 | $96,077 | BLOOD AND BLOOD PRODUCTS BHVAMC, OP4 TO ADMINISTRATIVE MODIFICATION |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-06-02 | −$54,225 | $41,852 | DEOBLIGATE EXCESS FUNDS FROM ORDER BLOOD AND BLOOD PRODUCTS BHVAHCS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI LFK8DDLYRHL6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26326N0628 | NETWORK CONTRACT OFFICE 23 (36C263) · Q301 · REFERENCE LABORATORY TESTING | $156,177 | FY2026 |
| 36C26326D0067 | NETWORK CONTRACT OFFICE 23 (36C263) · Q301 · REFERENCE LABORATORY TESTING | $0 | FY2026 |
| 36C26326P0170 | NETWORK CONTRACT OFFICE 23 (36C263) · Q301 · REFERENCE LABORATORY TESTING | $70,200 | FY2026 |
| 36C26326N0157 | NETWORK CONTRACT OFFICE 23 (36C263) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $96,268 | FY2026 |
| 36C26326D0004 | NETWORK CONTRACT OFFICE 23 (36C263) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C26324N0064 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $69,114 | FY2024 |
Other recipients under 6515 from NETWORK CONTRACT OFFICE 23 (36C263) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26326F0127 | NATUS MEDICAL INCORPORATED | NETWORK CONTRACT OFFICE 23 (36C263) | $80,267 | FY2026 |
| 36C26326P0713 | APEX INTEGRATED DISTRIBUTION INC. | NETWORK CONTRACT OFFICE 23 (36C263) | $36,834 | FY2026 |
| 36C26326P0725 | PROAIM AMERICAS, LLC. | NETWORK CONTRACT OFFICE 23 (36C263) | $27,716 | FY2026 |
| 36C26326P0724 | WHEELCHAIR DYNAMICS INC | NETWORK CONTRACT OFFICE 23 (36C263) | $24,412 | FY2026 |
| 36C26326F0124 | PHILIPS NORTH AMERICA LLC | NETWORK CONTRACT OFFICE 23 (36C263) | $779,096 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26325N0094_3600_36C26321D0004_3600 · retrieved 2026-09-26.